Agricultural & Food Biotech

Genetically Modified Crops

The most established agricultural biotech sector. Since the Flavr Savr tomato (1994), GM technology has reshaped global agriculture. Dominant GM crops: soybeans (>90% of US, mostly herbicide-tolerant), corn (>90% of US, herbicide tolerance plus Bt insect resistance), cotton (>95% of US), canola (>95% of Canadian), sugar beets (>95% of US).

Traits have evolved across generations: first-generation focused on input cost reduction (herbicide tolerance, insect resistance); second-generation on output improvements (drought tolerance, Golden Rice with vitamin A, non-browning fruits); third-generation — mostly still developing — on disease resistance, crop quality, and specialty compounds like omega-3 fatty acids in seed crops.

Despite three decades of commercial GM crops, the global landscape remains contested. The US and South America have embraced GM agriculture; most of Europe rejects it. The debate combines genuine scientific questions, economic interests, food sovereignty concerns, and cultural tensions. This is covered extensively in the Biotech Policy track (BP4).

Gene Editing in Crops

The newer wave uses gene editing — primarily CRISPR — rather than transgenic insertion. Advantages: precision, no foreign DNA in many edits, speed, and in the US, regulatory advantages (many CRISPR-edited crops fall outside USDA regulation entirely under the post-SECURE rule).

Examples: Calyxt high-oleic soybeans (CRISPR-edited oil with olive-oil-like properties — first commercially marketed CRISPR-edited food in the US), Sanatech high-GABA tomatoes (Japan's first commercially marketed gene-edited food, 2021), Pairwise mustard greens with reduced pungency, and Tropic Biosciences edited bananas targeting resistance to Panama disease (TR4), which currently threatens global banana production.

The pipeline is enormous. Whether this is good depends on values: promising from a productivity perspective, concerning from a food sovereignty perspective if it further concentrates power in companies that own the editing technologies, and ecologically uncertain depending on which traits are deployed and how broadly.

Cellular Agriculture and Precision Fermentation

Cultivated meat grows animal cells in bioreactors without whole animals. Singapore approved cultivated chicken in 2020 (Eat Just). The FDA cleared products from UPSIDE Foods and GOOD Meat in 2022–2023, with USDA follow-on approval. Major challenges: cost (orders of magnitude above conventional meat), scale (bioreactors large enough for meaningful meat quantities are unprecedented), and texture (producing complex muscle structure with fat marbling is technically difficult).

Precision fermentation uses engineered microorganisms to produce specific animal-identical proteins without animals. Examples: Perfect Day's whey proteins for dairy-free ice cream, Clara Foods' egg white protein, Geltor's animal-free collagen, Impossible Foods' heme. The technology works today — the challenge is achieving price parity with conventional alternatives.

Both cultivated meat and precision fermentation face the same fundamental economic challenge: the incumbents they're competing against (conventional animal agriculture) are cheap, efficient, deeply entrenched, and heavily subsidized. Technological capability is necessary but not sufficient for commercial success.

Animal Biotech

AquAdvantage salmon — engineered with a growth hormone gene from Chinook salmon — reaches market size in roughly half the normal time. FDA-approved 2015, commercial sales since 2017. Significant controversy over environmental risk if escaped to wild populations. GalSafe pigs lack the alpha-gal sugar that triggers allergic reactions, FDA-approved 2020 with potential food and medical applications. Acceligen polled cattle are gene-edited to be naturally hornless, avoiding painful dehorning procedures.

Xenotransplantation engineers pig organs for human transplant by removing pig-specific antigens, inactivating porcine retroviruses, and adding human compatibility genes. The 2022 University of Maryland pig-to-human heart transplant (patient survived two months) was a landmark. Companies eGenesis and Revivicor are advancing toward routine clinical use — success would dramatically expand organ availability for the ~100,000 US patients on transplant waiting lists.

Conservation applications include genetic rescue of endangered species (proposed for the black-footed ferret, the northern white rhino), invasive species control through gene drives, and heat tolerance engineering for livestock and wildlife adaptation to climate change.

Wait, Actually…

The genetic diversity of major food crops has collapsed dramatically in the past century — and biotech has nothing to do with it.

Before industrial agriculture, farmers maintained thousands of distinct crop varieties. Mexico had hundreds of corn landraces; Peru had thousands of potato varieties; India had over 100,000 rice cultivars in active cultivation as recently as 1950. Today, a handful of varieties dominate globally. Over 90% of US dairy cattle are Holsteins. Global commercial bananas are essentially one cultivar (Cavendish), currently being devastated by Panama disease (TR4) precisely because of its genetic uniformity.

This genetic narrowing happened before commercial GM crops existed. Conventional breeding, scaled industrial agriculture, and commodity supply chain demands drove it. GM and gene editing have actually been used in some cases to introduce disease resistance and drought tolerance back into elite cultivars that were lost in the narrowing. Whether biotech helps or hurts agricultural resilience depends on choices about who controls food systems and what they're optimized for — not the technology itself.

---